Skip to main content

HLA-B27 Testing in Practice

Analysis of testing for human leukocyte antigen B27 (HLA-B27) in a teaching center shows HLA-B27 testing was frequently performed by rheumatologists and nonrheumatologists for a broad spectrum of indications and primarily as a screening test. 

Data derived from the Mass General Brigham healthcare system, examined HLA-B27 testing and clinical associations between 1/1/2022 to 12/31/2022. Rheumatology referrals  were calculated for HLA-B27 positive and negative patients.

HLA-B27 tests was ordered in 1960 patients (62.4% female, average age 47.4 years).  A total of 10.9% of HLA-B27 tests were positive. 

The most common specialties testing for HLA-B27 were rheumatology (39.7%) and ophthalmology (21.4%). 

The most common indications for HLA-B27 testing were peripheral arthritis (33.0%), uveitis (22.0%), and back pain (16.7%). 

The majority of HLA-B27 tests (69.3%) were ordered concurrently with other autoantibody tests. Ophthalmology had the highest positive rate (15.4%) while reactive arthritis was the indication with the highest positive test rate (50%). 

Patients who were HLA-B27 positive were more likely to be referred to rheumatology (53% vs 32%, p=0.002).

Some odd findings were that HLA-B27 is often ordered with tests for ANA and rheumatoid arthritis.  Also half of HLA-B27 positive patients were not referred to rheumatology. 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject
×